Nicholette Zeliadt manages The Transmitters’s staff reporters and interns, and she commissions and edits news articles. She joined The Transmitter as news writer in 2014. Before that, she was a freelance writer and editor. Her work has appeared in The New York Times, Scientific American, Nature Medicine, Science and The Scientist.

Nicholette Zeliadt
Managing editor
The Transmitter
From this contributor

Leaving lasting marks with Tessa Montague
Spotted around the web: INSAR; cerebellar gene expression; pangenome
Spotted around the web: Mapping histones; COVID-19 births; acetaminophen lawsuits

New diagnostic code for PTEN syndrome may spur research
Education
- Ph.D. in environmental health, University of Minnesota
- B.A. in biochemistry, University of Iowa
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
How to teach students about science funding
As researchers reel over the uncertain state of U.S. federal funding, educating students on the business of science is more important than ever.

How to teach students about science funding
As researchers reel over the uncertain state of U.S. federal funding, educating students on the business of science is more important than ever.
Federal Register hold makes ‘end run’ around court pause on NIH funding freeze
U.S. National Institutes of Health-related updates to the Federal Register, which are required for the scheduling of study sections and advisory councils, are on hold indefinitely, according to an email reviewed by The Transmitter.

Federal Register hold makes ‘end run’ around court pause on NIH funding freeze
U.S. National Institutes of Health-related updates to the Federal Register, which are required for the scheduling of study sections and advisory councils, are on hold indefinitely, according to an email reviewed by The Transmitter.
Why hasn’t genetics taught us more about schizophrenia?
Large-scale genomics studies have failed to identify specific pathways that go awry in schizophrenia. Alternative approaches focusing on cellular, molecular and systems-level changes may be needed.

Why hasn’t genetics taught us more about schizophrenia?
Large-scale genomics studies have failed to identify specific pathways that go awry in schizophrenia. Alternative approaches focusing on cellular, molecular and systems-level changes may be needed.